Login / Signup

Risk of dementia after initiation of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in adults aged 40-69 years with type 2 diabetes: population based cohort study.

Anna ShinBo Kyung KooJun Young LeeEun Ha Kang
Published in: BMJ (Clinical research ed.) (2024)
SGLT-2 inhibitors might prevent dementia, providing greater benefits with longer treatment. As this study was observational and therefore prone to residual confounding and informative censoring, the effect size could have been overestimated. Randomised controlled trials are needed to confirm these findings.
Keyphrases
  • mild cognitive impairment
  • cognitive impairment
  • cross sectional